Why BofA and Bernstein See 55–70% Upside for ASML Stock

Two of Wall Street's most influential tech analysts, Bank of America and Bernstein, have issued strikingly bullish calls on ASML Holding NV, setting price targets that imply 55% to 70% upside from the stock's current level near $1,740. The bets are anything but incremental: they rest on a conviction that the market is fundamentally underestimating ASML's monopoly-powered leverage in an unprecedented AI-driven capacity expansion for advanced logic and DRAM chips.

The Bull Case, Piece by Piece

1. Unprecedented EUV shipment forecasts

Bernstein's most aggressive revision is its EUV shipment trajectory. The firm raised its 2027 forecast to 91 systems and its 2028 forecast to 113 systems — up sharply from earlier estimates of 86 and 87 . That is not a small tweak; it implies a step-change in volume that the rest of the Street has not yet modeled. ASML's own guidance supports the direction: management announced a 30% EUV capacity increase for 2027 and is investigating another 30% increase for 2028 .

2. EUV revenue compounding at 30% annually toward €42.7 billion by 2030

Bernstein forecasts EUV revenue will compound at roughly 30% per year, reaching €42.7 billion by 2030 . That is driven by both higher unit volume and strong average selling price expansion as ASML delivers throughput improvements on its existing Low-NA EUV tools and starts shipping higher-value High-NA systems . The firm expects total ASML revenue to hit €80 billion by 2030, a 24% premium over consensus estimates of €64 billion .

3. A 40x earnings multiple — a big departure from the past

Bernstein's $2,623 target applies a roughly 40x P/E multiple to forward earnings . That is a significant premium to ASML's historical average and far above what consensus uses. The justification: ASML's monopoly on EUV lithography makes it an "irreplaceable chokepoint of the AI era," and AI-driven demand for advanced logic and DRAM is creating a capex super-cycle that justifies a higher multiple .

4. Surging orders from TSMC and Intel

Both TSMC and Intel are in the middle of massive fab build-outs for 2nm and sub-2nm nodes, which require EUV and High-NA EUV systems. ASML's order backlog has stretched beyond a one-year lead time, and Susquehanna raised its target dramatically after channel checks confirmed the backlog was accelerating . ASML has stated it has already received substantially all orders needed for 2027 and a large number of orders for 2028, providing strong visibility into future demand .

5. BofA's "top pick" call — China threat dismissed

Bank of America has ASML as a "top pick" with a $2,845 price target on the U.S. ADR, which at the time of the call implied roughly 70% upside . Analyst Didier Scemama specifically addressed the China risk — a recent state-backed DUV breakthrough that caused a 7% stock drop — and argued it is not a real threat: ASML's technology moat is too wide for Chinese competitors to replicate at scale .

Why the Consensus Is So Much Lower

The average analyst target sits at ~$1,970 . That gap reflects a fundamentally different risk-reward assessment:

• Valuation sensitivity: GuruFocus flagged ASML as roughly 45.5% overvalued based on traditional DCF models. The bulls argue those models use the wrong growth assumptions.
• China uncertainty: Some analysts remain cautious about export controls, Chinese self-sufficiency efforts, and potential revenue loss from DUV restrictions .
• Execution risk: Hitting 91 EUV systems in 2027 and 113 in 2028 requires ASML to successfully scale its supply chain — something Citi recently flagged as "below expectations" relative to the most optimistic scenarios, noting that the 2027 boost would amount to about 85 machines compared with forecasts of about 90 to 100 .
• Cyclical risk: Semiconductor equipment is notoriously cyclical. The consensus price target effectively assumes the AI boom is already priced in and leaves less room for error.

The Crux of the Disagreement

The table below captures the key differences between the consensus view and the BofA/Bernstein view:

Factor	Consensus view (~$1,970)	BofA / Bernstein view (~$2,800)
EUV shipments 2027–2028	~65–75 units/year	91 → 113 units/year
EUV revenue CAGR	~15–20%	~30% to €42.7B by 2030
P/E multiple	~25–30x	~40x
China risk	Material overhang	Dismissed as non-threat
AI-driven capex cycle	Already reflected	Still underestimated

Bottom line: BofA and Bernstein are making a high-conviction bet that ASML's AI-driven volume and pricing trajectory will re-rate the stock to a level 55–70% above today's price, while the rest of the Street and value-focused models see more risk and less exponential growth. The stock's current price around $1,740 suggests the market is siding with caution — at least for now.